The first study, published yesterday in Clinical Infectious Diseases, includes results of a phase 3 clinical trial (MELODY), ...
Use of nirsevimab was associated with an approximately 80% reduction in illness due to respiratory syncytial virus (RSV) ...
The drug, nirsevimab, was effective against respiratory syncytial virus infections when used in the Yukon-Kuskokwim Delta, a ...
Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness.
University of Michigan and Centers for Disease Control and Prevention (CDC) investigators determined that both maternal ...
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
Respiratory syncytial virus (RSV) is an infectious respiratory disease that can look and sound a lot like a cold, with ...
RSV is the most common cause of hospitalization in infants under 1 year old. The infection can spread to the lungs and cause ...
Now that colder temperatures have arrived, the Illinois Department of Public Health (IDPH) is reminding Illinoisans to ...